Virtual Visits for Results Disclosure

Genetic Disease Clinical Trial

Official title:

Randomized Controlled Trial Evaluating Patient Satisfaction With Virtual Visits for Results Disclosure in the Brigham and Women's Hospital Cardiovascular Genetics Program

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03658382
• Other study ID #: 2017P000434
• Status: Withdrawn
• Phase: N/A
• Start date: September 2017
• Est. completion date: August 2018

Study information

• Verified date: September 2018
• Source: Brigham and Women's Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

As part of this study patients who have undergone genetic testing in the Brigham and Women's Hospital Cardiovascular Genetics program will be randomized to receive the results of their genetic testing either by telephone call or virtual visit. At the completion of the telephone call or virtual visit patients will receive a survey to assess their understanding of their results and their satisfaction with their care.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: August 2018
• Est. primary completion date: August 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years or older

• Undergoing genetic testing at BWH Cardiovascular Genetics clinic

Exclusion Criteria:

• Reside outside of Massachusetts

• Telephone or internet access unavailable

Related Conditions & MeSH terms

• Genetic Disease
• Genetic Diseases, Inborn

Intervention

Other:
• Virtual Visit
Patients will receive the results of their genetic testing via a virtual visit.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Brigham and Women's Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient satisfaction	Web-based survey focused on patient comprehension and satisfaction	within 7 days of results disclosure